Accessibility Menu
CellaVision Ab (publ) logo

CellaVision Ab (publ)

(OTC) CLVSF

Current Price$13.19
Market Cap$321.76M
Since IPO (2010)+641%
5 Year-58%
1 Year-27%
1 Month-15%

CellaVision Ab (publ) Financials at a Glance

Market Cap

$321.76M

Revenue (TTM)

SEK 730.59M

Net Income (TTM)

SEK 134.07M

EPS (TTM)

$0.59

P/E Ratio

22.70

Dividend

$0.30

Beta (Volatility)

-0.01 (Low)

Price

$13.19

Volume

6

Open

$14.67

Previous Close

$13.19

Daily Range

$13.19 - $14.67

52-Week Range

$13.19 - $19.28

Estimated Earnings Date

Jul 16, 2026

CLVSF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CellaVision Ab (publ)

Industry

Healthcare Equipment and Supplies

Employees

251

CEO

Simon Ostergaard, PhD, MBA

Headquarters

Lund, 223 62, SE

CLVSF Financials

Key Financial Metrics (TTM)

Gross Margin

68%

Operating Margin

24%

Net Income Margin

18%

Return on Equity

16%

Return on Capital

17%

Return on Assets

12%

Earnings Yield

4.41%

Dividend Yield

2.20%

Payout Ratio

44.48%

Stock Overview

Market Cap

$321.76M

Shares Outstanding

23.85M

Volume

6

Avg. Volume

6.453

Financials (TTM)

Gross Profit

SEK 519.88M

Operating Income

SEK 202.07M

EBITDA

SEK 236.69M

Operating Cash Flow

SEK 200.53M

Capital Expenditure

-SEK 86.27M

Free Cash Flow

SEK 114.26M

Cash & ST Invst.

SEK 188.22M

Total Debt

SEK 25.65M

CellaVision Ab (publ) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

SEK 166.43M

-14.6%

Gross Profit

SEK 113.99M

-16.9%

Gross Margin

68.49%

N/A

Market Cap

$321.76M

N/A

Market Cap/Employee

$1.41M

N/A

Employees

228

N/A

Net Income

SEK 22.51M

-45.8%

EBITDA

SEK 39.78M

-31.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

SEK 230.22M

+26.3%

Total Debt

SEK 22.43M

-2.3%

Accounts Receivable

SEK 119.43M

-12.6%

Inventory

SEK 122.06M

+2.3%

Long Term Debt

SEK 10.36M

+14.5%

Short Term Debt

SEK 12.07M

-13.2%

Return on Assets

11.81%

N/A

Return on Invested Capital

17.16%

N/A

Free Cash Flow

SEK 45.92M

+14.7%

Operating Cash Flow

SEK 62.43M

+1.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CALZFPolyNovo Limited
$0.68+0.00%
BOIRFBoiron S.A.
$31.90+6.33%
GSGTFGenSight Biologics S.A.
$0.19+0.00%
LBLTFLattice Biologics Ltd.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$14.98+0.02%
NOKNokia
$14.80+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%

Questions About CLVSF

What is the current price of CellaVision Ab (publ)?

CellaVision Ab (publ) is trading at $13.19 per share.

What is the 52-week range for CellaVision Ab (publ)?

Over the past 52 weeks, CellaVision Ab (publ) has traded between $13.19 and $19.28.

How much debt does CellaVision Ab (publ) have?

As of the most recent reporting period, CellaVision Ab (publ) reported total debt of SEK 2.35M.

How much cash does CellaVision Ab (publ) have on hand?

CellaVision Ab (publ) reported SEK 24.17M in cash and cash equivalents in its most recent financial results.

What is CellaVision Ab (publ)’s dividend yield?

CellaVision Ab (publ) currently has a dividend yield of 2.20%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.